India Newborn Screening Market Size & Outlook, 2023-2030

The newborn screening market in India is expected to reach a projected revenue of US$ 75.5 million by 2030. A compound annual growth rate of 10.4% is expected of India newborn screening market from 2024 to 2030.
Revenue, 2023 (US$M)
$37.9
Forecast, 2030 (US$M)
$75.5
CAGR, 2024 - 2030
10.3%
Report Coverage
India

India newborn screening market highlights

  • The India newborn screening market generated a revenue of USD 37.9 million in 2023 and is expected to reach USD 75.5 million by 2030.
  • The India market is expected to grow at a CAGR of 10.4% from 2024 to 2030.
  • In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2023.
  • Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.


Newborn screening market data book summary

Market revenue in 2023USD 37.9 million
Market revenue in 2030USD 75.5 million
Growth rate10.4% (CAGR from 2023 to 2030)
Largest segmentTandem mass spectrometry
Fastest growing segmentElectrophoresis
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis
Key market players worldwideBio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp


Other key industry trends

  • In terms of revenue, India accounted for 4.7% of the global newborn screening market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Thailand newborn screening market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 75.5 million by 2030.

Tandem mass spectrometry was the largest segment with a revenue share of 24.8% in 2023. Horizon Databook has segmented the India newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.


With dense and growing population and rising prevalence of critical conditions, India is expected to provide great platform for growth of newborn screening market. The cost-conscious behavior of the people and comparatively low per capita health expenditure may hamper the market penetration in the country.

However, the strategic plans by focusing on the premier class and growing disposable incomes along with developing economy may help in growing the patient awareness level. Recent government initiatives by agencies such as Public Health Foundation are expected to change the market scenario for latest technology involved in the healthcare sector.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Newborn Screening Market Scope

Newborn screening market segmentation & scope
Tandem Mass Spectrometry
Pulse Oximetry
Enzyme-based Assay
DNA Assays
Electrophoresis
Others
Dry Blood Spot Test
CCHD
Hearing Screen
Instruments
Reagents

Newborn Screening Market Companies

Name Profile # Employees HQ Website

India newborn screening market size, by technology, 2018-2030 (US$M)

India Newborn Screening Market Outlook Share, 2023 & 2030 (US$M)

India newborn screening market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more